Westwood Holdings Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Westwood Holdings Group Inc

  • $12.6 Billion
  • Q3 2024

A detailed history of Westwood Holdings Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Westwood Holdings Group Inc holds 12,114 shares of REGN stock, worth $8.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,114
Previous 12,301 1.52%
Holding current value
$8.5 Million
Previous $12.9 Million 1.5%
% of portfolio
0.1%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $191,504 - $224,729
-187 Reduced 1.52%
12,114 $12.7 Million
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $178,406 - $216,380
-202 Reduced 1.62%
12,301 $12.9 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $240,115 - $264,231
-266 Reduced 2.08%
12,503 $12 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $139,532 - $158,706
-180 Reduced 1.39%
12,769 $11.2 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $679,985 - $829,171
-982 Reduced 7.05%
12,949 $10.7 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $217,009 - $257,408
-310 Reduced 2.18%
13,931 $10 Million
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $1.01 Billion - $1.23 Billion
-1,483,601 Reduced 99.05%
14,241 $11.7 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $1.04 Billion - $1.13 Billion
1,480,215 Added 8397.43%
1,497,842 $67.6 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $1.13 Million - $1.42 Million
-1,965 Reduced 10.03%
17,627 $12.1 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $1.12 Million - $1.51 Million
-2,041 Reduced 9.43%
19,592 $11.6 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $41,063 - $48,191
-69 Reduced 0.32%
21,633 $15.1 Million
Q4 2021

Feb 25, 2022
BUY
$543.48 - $670.97 $594,023 - $733,370
1,093 Added 5.3%
21,702 $13.7 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $80,364 - $95,334
-140 Reduced 0.67%
20,609 $12.5 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $3.28 Million - $3.87 Million
-6,936 Reduced 25.05%
20,749 $11.6 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $1.49 Million - $1.83 Million
3,331 Added 13.68%
27,685 $13.1 Million
Q4 2020

Apr 13, 2021
BUY
$478.3 - $607.98 $6,696 - $8,511
14 Added 0.06%
24,354 $11.8 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $139,663 - $177,530
292 Added 1.21%
24,340 $11.8 Million
Q3 2020

Nov 10, 2020
SELL
$544.75 - $658.21 $49,572 - $59,897
-91 Reduced 0.38%
24,048 $13.5 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $3.69 Million - $4.82 Million
7,490 Added 44.99%
24,139 $15.1 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $3.2 Million - $4.71 Million
9,533 Added 133.97%
16,649 $8.13 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $28,235 - $38,780
-103 Reduced 1.43%
7,116 $2.67 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $186,499 - $217,141
682 Added 10.43%
7,219 $2 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $232,489 - $321,900
-776 Reduced 10.61%
6,537 $2.05 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $883,317 - $1.04 Million
2,374 Added 48.07%
7,313 $3 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $880,520 - $1.06 Million
-2,622 Reduced 34.68%
4,939 $1.85 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $471,229 - $548,220
-1,342 Reduced 15.07%
7,561 $3.06 Million
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $563,223 - $682,735
1,979 Added 28.58%
8,903 $3.07 Million
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $2.19 Million - $2.73 Million
6,924 New
6,924 $2.38 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Westwood Holdings Group Inc Portfolio

Follow Westwood Holdings Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email